<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03938831</url>
  </required_header>
  <id_info>
    <org_study_id>K2019-03 58-003</org_study_id>
    <nct_id>NCT03938831</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine and Delirium in Elderly Patients</brief_title>
  <official_title>Effect of Dexmedetomidine in Postoperative Delirium in Hip Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University Guro Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea University Guro Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators investigates the effect of perioperative dexmedetomidine 0.5 ug/kg/hr followed
      by a postoperative continuous infusion fentanyl-based PCA(Patient-Controlled Analgesia) drug
      mixed with dexmedetomidine 0.2ug/kg/hr for two days on reducing postoperative delirium and
      postoperative rescue analgesics in elderly patients who undergo hip surgery. The other half
      of patients received fentanyl-based PCA only.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Elderly patients are susceptible to postoperative delirium. Delirium occurs in 10~60% and is
      associated with longer hospital stays, increased costs, and morbidity. Postoperative delirium
      usually occurs 2~3 days after surgery. Intraoperative infusion of dexmedetomidine lacks
      preventing postoperative delirium in elderly noncardiac major surgery.

      We hypothesized postoperative dexmedetomidine for two days as a mixture drug of
      fentanyl-based PCA could reduce the incidence of postoperative delirium. We compared this
      effect with other control group who received fentanyl-based PCA only.

      We also investigate EEG patterns of patients during emergence and compared the EEG patterns
      who developed delirium postoperatively in PACU(Postanesthesia care unit) or general ward.
      Dexmedetomidine has analgesic effect. We expected postoperative dexmedetomidine has benefits
      of opioid sparing effects.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">February 28, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized control</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>delirium</measure>
    <time_frame>2 days</time_frame>
    <description>reduction of incidence of delirium</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Delirium, Dexmedetomidine, Postoperative PCA</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dexmedetomidine mixture with fentanyl-based PCA infusion for 2 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Fentanyl-based PCA infusion for 2 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>dexmedetomidine 0.5 micg/kg/hr infusion during operation and followed by 0.2 mic/kg/hr with fentanyl-based PCA mixture for 2 days</description>
    <arm_group_label>dexmedetomidine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl-based PCA infusion</intervention_name>
    <description>Fentanyl-based PCA infusion</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>dexmedetomidine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: over 65 yrs old elderly patient who undergo elective hip surgery and
        ASA(The American Society of Anesthesiologists) physical status I-III

        Exclusion Criteria:

        history of dementia, drug abuser, hypersensitivity to dexmedetomidine, fentanyl, propofol,
        disable to speech, reject the clinical study, hemodynamic instability during surgery, an
        illiterate, pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Il-Ok Lee, professor</last_name>
    <role>Study Chair</role>
    <affiliation>Korea University Guro Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>KoreaUniversity Guro Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Guro-ku</state>
        <zip>08308</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 3, 2019</study_first_submitted>
  <study_first_submitted_qc>May 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2019</study_first_posted>
  <last_update_submitted>August 26, 2019</last_update_submitted>
  <last_update_submitted_qc>August 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea University Guro Hospital</investigator_affiliation>
    <investigator_full_name>Il Ok Lee</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

